Home L'Amy America L'Amy x BOSMA

L’Amy x BOSMA

bosma enterprisesBosma enterprises is a recognized organization with their commitment to creating opportunities for individuals with visual impairments. L’Amy America collaborates with Bosma Enterprises to perform the packaging of sunglasses for Two Blind Brothers. This partnership pushes beyond the boundaries of traditional business by delivering high-quality sunglasses while offering meaningful employment opportunities for people who are blind or visually impaired.

bosma group

L’Amy’s ongoing commitment to corporate social responsibility while giving back to the optical community continues to foster environments where everyone, regardless of ability, can participate in creating real change.

“Giving back to the community is incredibly important to our mission at L’Amy America. Through this unique partnership with Bosma Enterprises, together we are creating opportunities for individuals with visual impairments to showcase their talents and contribute to shared success,” says Stephen Rappoport, CEO of L’Amy America.inside of bosma

Read more about L’Amy America brands on WO here.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

- Advertisment -

Most Popular

Twelve84 Eyewear and Optical X Inc. Secure Over $2M in Funding to Drive Growth

HealthX Ventures, a Wisconsin-based venture capital firm, has led a seed investment in Optical X Inc., parent company of Twelve84® and founded by CEO,...

Capitol Optometry Grows: New Office and Advanced Care

Nichole R. Moos, OD, says the opportunity to become a practice owner fell into her lap in January 2019. Tiffany Lu, OD, a friend...

January is Mental Wellness Month: Report Reveals Happiest, Healthiest U.S. States

January is mental wellness month. New research reveals that North Dakota, Vermont and Nebraska are the happiest and healthiest states in the U.S., while...

Breakthrough Gene Editing Technique Offers Hope for Stargardt Disease Patients

Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most common form of inherited macular degeneration. This...